International Journal of Oral Biology

The Korean Academy of Oral Biology (대한구강생물학회)
권호 표지
DOI QR코드

DOI QR Code

Effect of Hexane Extract of Galla Rhois on Inflammatory Alveolar Bone Loss

  • Kim, Hyun-Jin (Institute of Biomaterial.Implant, Department of Oral Anatomy, School of Dentistry, Wonkwang University)
  • Received : 2016.02.23
  • Accepted : 2016.03.03
  • Published : 2016.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

One of functions of Galla Rhois (GR) is reportedly an anti-inflammatory effect on the several inflammatory diseases. However, an effect of GR related to periodontitis has not been investigated. In the present study, we examined the effect of the hexane extract of Galla Rhois (GR-H) on periodontitis. Cytotoxicity was assessed by MTS analysis using human gingival fibroblast (hGF) cells. Experimental periodontitis was induced by injecting E.coli LPS into the palatal gingiva maxillary molar thrice weekly for 3 weeks (LPS group). GR-H diluted in 1xPBS was orally administrated using a syringe at 30 mg/kg body weight and 100 mg/kg body weight once a day (GR-H group). GR-H effect on the alveolar bone loss (ABL) was digitized with a micro-CT. GR-H treatment at concentrations exceeding 0.5 mg/ml showed cytotoxic effect in hGF cells. The micro-CT among groups were presented for the different distances from cemento-enamel junction (CEJ) to alveolar bone crest (ABC). The results indicated an inhibitory effect on alveolar bone loss for orally administered GR-H in a model of LPS-induced periodontitis.

Keywords

References

  1. Lohinai Z, Stachlewitz R, Szekely AD, Feher E, Dezsi L, Szabo C. Evidence for the expression of cyclooxygenase-2 enzyme in periodontitis. Life Sci. 2001;70:279-290. https://doi.org/10.1016/S0024-3205(01)01391-1
  2. Vane JR, Bakhle YS, Botting RM. Cycloxygenase 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120. https://doi.org/10.1146/annurev.pharmtox.38.1.97
  3. Palombo EA. Traditional medicinal plant extracts and natural products with activity against oral bacteria: potential application in the prevention and treatment of oral diseases. Evid Based Complement Alternat Med. 2011;2011:1-15. doi: 10.1093/ecam/nep067.
  4. Djakpo O, Yao W. Rhus chinensis and Galla Chinensisfolklore to modern evidence. Phytother Res. 2010;24:1739-1747. doi: 10.1002/ptr.3215.
  5. Chen JC, Ho TY, Chang YS, Wu SL, Li CC, Hsiang CY. Identification of Escherichia coli enterotoxin inhibitors from traditional medicinal herbs by in silico, in vitro, and in vivo analyses. J Ethnopharmacol. 2009;121:372-378. doi: 10.1016/j.jep.2008.11.011.
  6. Tian F, Li B, Ji B, Yang J, Zhang G, Chen Y, Luo Y. Antioxidant and antimicrobial activities of consecutive extracts from Galla chinensis: The polarity affects the bioactivities. Food chemistry. 2009;113:173-179.
  7. Kang MS, Oh JS, Kang IC, Hong SJ, Choi CH. Inhibitory effect of methyl gallate and gallic acid on oral bacteria. J Microbiol. 2008;46:744-750. doi: 10.1007/s12275-008-0235-7.
  8. Liu Z, Liu T, Li J, Zhou X, Zhang J. The effect of Galla chinensis on the demineralization of enamel. Sichuan Da Xue Xue Bao Yi Xue Ban. 2003;34:507-509.
  9. Cekici A, Kantarci A, Hasturk H, Van Dyke TE. Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol. 2000. 2014;64:57-80. doi: 10.1111/prd.12002.
  10. Patil C, Rossa C, Kirkwood KL. Actinobacillus actinomycetemcomitans lipopolysaccharide induces interleukin‐6 expression through multiple mitogenactivated protein kinase pathways in periodontal ligament fibroblasts. Oral microbiology and immunology. 2006;21:392-400. https://doi.org/10.1111/j.1399-302X.2006.00314.x
  11. Ara T, Kurata K, Hirai K, Uchihashi T, Uematsu T, Imamura Y, Furusawa K, Kurihara S, Wang PL. Human gingival fibroblasts are critical in sustaining inflammation in periodontal disease. J Periodontal Res. 2009;44:21-27. doi: 10.1111/j.1600-0765.2007.01041.x.
  12. Ren L, Jiang ZQ, Fu Y, Leung WK, Jin L. The interplay of lipopolysaccharide‐binding protein and cytokines in periodontal health and disease. J Clin Periodontol. 2009;36:619-626. doi: 10.1111/j.1600-051X.2009.01436.x.
  13. Li JP, Chen Y, Ng CH, Fung ML, Xu A, Cheng B, Tsao SW, Leung WK. Differential expression of Toll‐like receptor 4 in healthy and diseased human gingiva. J Periodontal Res. 2014 doi: 10.1111/jre.12173.
  14. Kim SH, Park HH, Lee S, Jung CD, Choi BJ, Kim SY, Kim SH, Kim DK, Park JS, Chae BS, Shin TY. The anti-anaphylactic effect of the gall of Rhus javanica is mediated through inhibition of histamine release and inflammatory cytokine secretion. Int Immunopharmacol. 2005;5:1820-1829.
  15. Park PH, Hur J, Kim YC, An RB, Sohn DH. Involvement of heme oxygenase-1 induction in inhibitory effect of ethyl gallate isolated from Galla Rhois on nitric oxide production in RAW 264.7 macrophages. Arch Pharm Res. 2011;34:1545-1552. doi: 10.1007/s12272-011-0917-2.
  16. Hasturk H, Kantarci A, Ohira T, Arita M, Ebrahimi N, Chiang N, Petasis NA, Levy BD, Serhan CN, Van TE. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J. 2006;20:401-403. https://doi.org/10.1096/fj.05-4724fje
  17. Chae HS, Kang OH, Choi JG, Oh YC, Lee YS, Brice OO, Chong MS, Lee KN, Shin DW, Kwon DY. Methyl gallate inhibits the production of interleukin-6 and nitric oxide via down-regulation of extracellular-signal regulated protein kinase in RAW 264.7 cells. Am J Chin Med. 2010;38:973-983. https://doi.org/10.1142/S0192415X10008391
  18. Lee BA, Lee HS, Jung YS, Kim SW, Lee YW, Chang SH, Chung HJ, Kim OS, Kim YJ. The Effects of a Novel Botanical Agent on Lipopolysaccharide-Induced Alveolar Bone Loss in Rats. J Periodontol. 2013;84:1221-1229. doi: 10.1902/jop.2012.120460.
  19. Guimaraes MR, de Aquino SG, Coimbra LS, Spolidorio LC, Kirkwood KL, Rossa C Jr. Curcumin modulates the immune response associated with LPS-induced periodontal disease in rats. Innate Immun. 2012:18:155-163. doi: 10.1177/1753425910392935.
  20. Park CH, Abramson ZR, Taba M Jr, Jin Q, Chang J, Kreider JM, Goldstein SA, Giannobile WV. Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol. 2007;78:273-281. https://doi.org/10.1902/jop.2007.060252
  21. Gürkan A, Emingil G, Nizam N, Doganavsargil B, Sezak M, Kutukculer N, Atilla G. Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharideinduced experimental periodontitis in rats. J Periodontol. 2009;80:1655-1664. doi: 10.1902/jop.2009.090031.
  22. Yamano E, Miyauchi M, Furusyo H, Kawazoe A, Ishikado A, Makino T, Tanne K, Tanaka E, Takata T. Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis. Lab Invest. 2010;90: 1236-1246. doi: 10.1038/labinvest.2010.80.
  23. Hamada Y, Kondoh T, Noguchi K, Iino M, Isono H, Ishii H, Mishima A, Kobayashi K, Seto K. Application of limited cone beam computed tomography to clinical assessment of alveolar bone grafting: a preliminary report. Cleft Palate Craniofac J. 2005;42:128-137. https://doi.org/10.1597/03-035.1
  24. Van Oosterwyck H, Duyck J, Vander Sloten JV, Van der Perre G, Jansen J, Wevers M, Naert I. The use of microfocus computerized tomography as a new technique for characterizing bone tissue around oral implants. J Oral Implantol. 2000;26:5-12. https://doi.org/10.1563/1548-1336(2000)026<0005:TUOMCT>2.3.CO;2
  25. Mengel R, Candir M, Shiratori K, Flores-de-Jacoby L. Digital volume tomography in the diagnosis of periodontal defects: an in vitro study on native pig and human mandibles. J Periodontol. 2005;76:665-673. https://doi.org/10.1902/jop.2005.76.5.665
  26. Ebina H, Hatakeyama J, Onodera M, Honma T, Kamakura S, Shimauchi H, Sasano Y. Micro‐CT analysis of alveolar bone healing using a rat experimental model of critical‐size defects. Oral Dis. 2009;15:273-280. doi: 10.1111/j.1601-0825.2009.01522.x.
  27. Wada T, Nakashima T, Hiroshi N, Penninger JM. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med. 2006;12:17-25.